3 Min Read
(Reuters) -Merck & Co Inc said on Thursday it would take a bigger hit to sales this year than previously expected due to a resurgence in COVID-19 cases that has hurt demand for drugs that need to be given by doctors.
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid
The pandemic is expected to shave 3% from overall sales, more than the previously projected 2%, after it resulted in a $600 million hit to Merck’s first-quarter sales.
Merck shares fell 3.1% to $74.73 after the company also missed first-quarter earnings estimates.
By Reuters Staff
4 Min Read
(Reuters) - Vital medical supplies began to reach India on Tuesday as hospitals starved of life-saving oxygen and beds turned away coronavirus patients, and a surge in infections pushed the death toll towards 200,000.
People lower the body of Laeeq Ahmed, 67, who died from the coronavirus disease (COVID-19), into a grave during his funeral at a graveyard in New Delhi, India, April 27, 2021. REUTERS/Adnan Abidi
DEATHS AND INFECTIONS
EUROPE Some Russians who have taken COVID-19 antibody tests and found their antibodies have fallen are having third and fourth shots of the Sputnik V vaccine, but researchers in the country suggest they are unnecessary.
Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.
By Reuters Staff
1 Min Read
April 23 (Reuters) - The EU medicines regulator on Friday approved an expansion in manufacturing capacity of the Pfizer/BioNtech COVID-19 vaccine in Belgium, while recommending an approval for a new filling line at Moderna’s site in Spain. (Reporting by Yadarisa Shabong in Bengaluru)
By Reuters Staff
April 23 (Reuters) - EMA SAYS INCREASE IN VACCINE MANUFACTURING CAPACITY AND SUPPLY FOR COVID-19 VACCINES FROM BIONTECH/PFIZER AND MODERNA EMA - APPROVED AN INCREASE IN BATCH SIZE AND ASSOCIATED PROCESS SCALE UP AT PFIZER’S VACCINE MANUFACTURING SITE IN PUURS, BELGIUM EMA SAYS EMA HAS APPROVED AN INCREASE IN BATCH SIZE AND ASSOCIATED PROCESS SCALE UP AT PFIZER’S VACCINE MANUFACTURING SITE IN PUURS, BELGIUM EMA SAYS CHMP ALSO RECOMMENDED APPROVAL OF A NEW FILLING LINE AT MODERNA’S FINISHED PRODUCT MANUFACTURING SITE FOR EU IN ROVI, SPAIN EMA SAYS RECOMMENDATION BY AGENCY’S CHMP EXPECTED TO HAVE SIGNIFICANT IMPACT ON SUPPLY OF COMIRNATY, COVID-19 VACCINE, IN EUROPEAN UNION